Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1129216 10.3389/fphar.2022.1129216 Pharmacology Retraction Retraction: Long noncoding RNA FOXD2-AS1 promotes the malignancy of cervical cancer by sponging microRNA-760 and upregulating hepatoma-derived growth factor Frontiers Editorial Office 10.3389/fphar.2022.1129216 Frontiers Editorial Office *

Approved by: Olivier Feron, Université catholique de Louvain, Belgium

 *Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology

 05 01 2023 2022 13 1129216 21 12 2022 21 12 2022 Copyright © 2023 Frontiers Editorial Office. 2023 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Original Research Article Long noncoding RNA FOXD2-AS1 promotes the malignancy of cervical cancer by sponging microRNA-760 and upregulating hepatoma-derived growth factor Dou X, Zhou Q, Wen M, Xu J, Zhu Y, Zhang S and Xu X (2020). Front. Pharmacol. 10:1700. doi: 10.3389/fphar.2019.01700

Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors have agreed to the retraction.